Tareq W. Haddad

FDA investigator

Appears on 3 documents from 2025 to 2026, most often at sites in California. Most often cites sanitation (21 CFR 211.56(a)).

3
Documents on file
1.7
Observations per 483
2025
First seen
2026
Most recent

What they cite most

From 5 observations
  • 21 CFR 211.56(a)
    Sanitation
    1
  • 21 CFR 211.80
    General requirements
    1
  • 21 CFR 211.84
    Testing and approval or rejection of components, drug product containers, and closures
    1
  • 21 CFR 212.30(a)
    What requirements must my facilities and equipment meet?
    1
  • 21 CFR 310.305
    Records and reports concerning adverse drug experiences on marketed prescription drugs for human use without approved new drug applications
    1

Activity by year

2025: 1, 2026: 2

Where

California 1 · Mississippi 1 · Washington 1

Is Tareq W. Haddad coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

3 documents, newest first
FirmOpen
483 Jubilant HollisterStier LLCJun 17, 2026 · Spokane, Washington
483 Cardinal Health 414, LLCMar 18, 2026 · Jackson, Mississippi
483 MedisourceRxJun 10, 2025 · Los Alamitos, California

About this profile

What does Tareq W. Haddad inspect?

Tareq W. Haddad appears on 3 documents on file covering 3 sites, most often in California.

What do they cite most often?

21 CFR 211.56(a) (sanitation), followed by 21 CFR 211.80 and 21 CFR 211.84.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Tareq W. Haddad is dated Jun 17, 2026.